Redhill Biopharma
RDHL
47 hedge funds and large institutions have $77.5M invested in Redhill Biopharma in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 6 closing their positions.
186% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 7
100% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 6
66% more capital invested
Capital invested by funds: $46.6M → $77.5M (+$31M)
15% more funds holding
Funds holding: 41 → 47 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
1% less call options, than puts
Call options by funds: $2.6M | Put options by funds: $2.63M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$1.12M |
| 2 |
SC
Sculptor Capital
New York
|
+$894K |
| 3 |
State Street
Boston,
Massachusetts
|
+$738K |
| 4 |
Goldman Sachs
New York
|
+$582K |
| 5 |
AIP
ARS Investment Partners
New York
|
+$484K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$344K |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$189K |
| 3 |
Bank of New York Mellon
New York
|
-$180K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$156K |
| 5 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$57.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LC
51
Lindbrook Capital
Calabasas,
California
| $1K | – | – | – |
|
|
QCG
52
Quadrant Capital Group
Cincinnati,
Ohio
| $1K | – | – | – |
|
|
S
53
SignatureFD
Atlanta,
Georgia
| $1K | – | – | – |
|
54
US Bancorp
Minneapolis,
Minnesota
| $1K | – | – | – |
|
|
55
Simplex Trading
Chicago,
Illinois
| – | -$156K | -19 | -56% |
|
|
FDCDDQ
56
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$23.7K | -4 | Closed |
|
|
EDRH
57
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – | -$21K | -3 | Closed |
|
|
FANJ
58
Financial Architects (New Jersey)
Marlton,
New Jersey
| – | -$13K | -2 | Closed |
|
|
WFMPM
59
Woodley Farra Manion Portfolio Management
Indianapolis,
Indiana
| – | -$14K | -2 | Closed |
|
|
KPW
60
Kore Private Wealth
New York
| – | -$6K | -1 | Closed |
|
|
SPIA
61
Steward Partners Investment Advisory
New York
| – | -$3K | -1 | Closed |
|
RDHL Hedge Fund Activity: Q3 2020 in Review
47 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q3 2020, worth a combined $77.5M — up 66% from $46.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new RDHL positions and 6 closed out — a net gain of 6 holders — while 20 added to existing stakes and 7 trimmed.
The largest buyer was Wells Fargo, adding an estimated $1.12M. The largest seller was Group One Trading, cutting an estimated $344K.
- 47 institutional investors held Redhill Biopharma (RDHL) as of Q3 2020, up from 41 in Q2 2020.
- Funds reported $77.5M of Redhill Biopharma stock for Q3 2020, up 66% quarter-over-quarter.
- 12 funds opened new Redhill Biopharma positions in Q3 2020 and 6 closed out, a net change of +6 holders.
- The largest Redhill Biopharma buyer in Q3 2020 was Wells Fargo, an estimated $1.12M added.
- The largest Redhill Biopharma seller in Q3 2020 was Group One Trading, an estimated $344K sold.
Based on aggregated 13F filings for Q3 2020.